ADVOCATE. CONNECT. INNOVATE.

CLSA Wire

CLSA Board Engages Lawmakers in Washington D.C. During Capitol Hill Advocacy Day

May 25, 2018
By 
Adam Lotspike

On May 23, 15 members of CLSA’s Board of Directors spent a full day on Capitol Hill meeting with nearly 2 dozen key legislators and senior staff on issues of importance to California’s biomedical innovation ecosystem.

Meetings included: House Majority Leader Kevin McCarthy (R-Bakersfield), Reps. Nanette Barragán (D-Carson), Salud Carbajal (D-Santa Barbara), Tony Cárdenas (D-San Fernando Valley), Lou Correa (D-Santa Ana), Susan Davis (D-San Diego), Jimmy Gomez (D-Los Angeles), Jared Huffman (D-San Rafael), Jimmy Panetta (D-Monterey), Jackie Speier (D-San Mateo/South San Francisco), Eric Swalwell (D-East Bay), David Valadao (R-Hanford), and Mimi Walters (R-Irvine). In addition, we convened a roundtable discussion with members of the New Democrat Coalition, including: Tony Cárdenas (D-San Fernando Valley), Lou Correa (D-Santa Ana), Susan Davis (D-San Diego), Scott Peters (D-San Diego), Raul Ruiz, MD (D-Palm Desert) and Norma Torres (D-Pomona), and senior staff for Reps. Ami Bera, MD (D-Sacramento) and Julia Brownley (D-Thousand Oaks).

CLSA’s board members discussed issues including: how public and private insurers can better value medical innovation through coverage and payment policies; the importance of a patent system that preserves the ability for biomedical innovators to enforce their patents; our support for predictable and sustained NIH funding for basic research; the importance of a transparent and predictable FDA regulatory environment, including corresponding payment transparency and predictability for novel technologies.

Click here to view photos. Questions? Please contact Jenny Nieto Carey, CLSA’s Vice President of Federal Government Relations & Alliance Development (jcarey@califesciences.org).